Related Experiment Video
Updated: Dec 23, 2025

Author Spotlight: Flow Cytometric Determination of Pyroptosis in Avian Cells
Published on: May 31, 2024
Role of pyroptosis in liver diseases
Abdullah Al Mamun1, Yanqing Wu2, Chang Jia3
1Molecular Pharmacology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, Zhejiang Province, China.
Abstract:
Pyroptosis is known as a novel form of pro-inflammatory cell death program, which is exceptional from other types of cell death programs. Particularly, pyroptosis is characterized by Gasdermin family-mediated pore formation and subsequently cellular lysis, also release of several pro-inflammatory intracellular cytokines. In terms of mechanism, there are two signaling pathways involved in pyroptosis, including caspase-1, and caspase-4/5/11 mediated pathways. However, pyroptosis plays important roles in immune defense mechanisms. Recent studies have demonstrated that pyroptosis plays significant roles in the development of liver diseases. In our review, we have focused on the role of pyroptosis based on the molecular and pathophysiological mechanisms in the development of liver diseases. We have also highlighted targeting of pyroptosis for the therapeutic implications in liver diseases in the near future.
Insights
Pyroptosis, a programmed cell death, involves Gasdermin pores and cytokine release. This review explores pyroptosis mechanisms and its role in liver disease development and potential therapies.
Area of Science:
- Immunology
- Cell Biology
- Hepatology
Background:
- Pyroptosis is a distinct pro-inflammatory programmed cell death pathway.
- It is characterized by Gasdermin-mediated pore formation, cellular lysis, and cytokine release.
- Key signaling pathways involve caspase-1 and caspase-4/5/11.
Purpose of the Study:
- To review the molecular and pathophysiological mechanisms of pyroptosis in liver disease.
- To highlight the significant roles of pyroptosis in the development of liver diseases.
- To discuss the therapeutic potential of targeting pyroptosis for liver diseases.
Main Methods:
- Literature review focusing on pyroptosis and liver diseases.
- Analysis of molecular mechanisms of pyroptosis.
- Examination of pathophysiological roles in liver disease progression.
Main Results:
- Pyroptosis is implicated in the pathogenesis of various liver diseases.
- Specific molecular pathways of pyroptosis contribute to liver injury.
- Targeting pyroptosis presents a promising therapeutic avenue for liver conditions.
Conclusions:
- Pyroptosis is a critical factor in liver disease development.
- Understanding pyroptosis mechanisms is key to developing novel treatments.
- Targeting pyroptosis offers future therapeutic strategies for liver diseases.
Related Concept Videos
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Apoptosis

